Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report
- Authors
- Yun, Jina; Kim, Seok Jin; Won, Jong Ho; Choi, Chul Won; Eom, Hyeon Seok; Kim, Jin Seok; Kim, Min Kyoung; Kwak, Jae-Yong; Kim, Won Seog; Suh, Cheolwon
- Issue Date
- Sep-2010
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- Lymphoma; Ovary; Prognosis; Rituximab; Chemotherapy; B-cell; T-cell
- Citation
- LEUKEMIA RESEARCH, v.34, no.9, pp 1175 - 1179
- Pages
- 5
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- LEUKEMIA RESEARCH
- Volume
- 34
- Number
- 9
- Start Page
- 1175
- End Page
- 1179
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/115813
- DOI
- 10.1016/j.leukres.2010.02.010
- ISSN
- 0145-2126
1873-5835
- Abstract
- Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients. (C) 2010 Elsevier Ltd. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.